Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma

AIMS: This study aimed to (a) assess the effectiveness and safety of apatinib as a subsequent treatment for patients with sorafenib-resistant hepatocellular carcinoma (HCC), and (b) identify the clinical factors influencing their treatment outcomes. METHODS: The electronic medical records of consecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yingqiang, Huang, Guihua, Miao, Hongfei, Song, Ze, Zhang, Xiaoying, Fan, Wenzhe, Wang, Yu, Li, Jiaping, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378719/
https://www.ncbi.nlm.nih.gov/pubmed/32754228
http://dx.doi.org/10.1177/1758835920937422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378719/
https://www.ncbi.nlm.nih.gov/pubmed/32754228
http://dx.doi.org/10.1177/1758835920937422

Ejemplares similares